SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?


To: Michael C Quesnel who wrote (5090)6/8/1998 2:20:00 PM
From: Rocketman  Respond to of 9719
 
I vote for stock price Poor Performance. For GENZL, I think it is a long term project for them to get up to decent revenues in the knee repair business (slow and steady), and that they will continue to plow money into long term R&D and thus will not reach profitability on the knee repair alone. Thus, even though they have a "product" on the market, they won't get the respect on the street that a profitable company would achieve, and thus I think the shares will continue flat versus other things out there. At the time we sold, we wanted to use the funds for other things. I think this is also the case with REGN, but V1 should confirm on this.

Rman